scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023880222 |
P356 | DOI | 10.1186/1475-2840-10-83 |
P932 | PMC publication ID | 3196906 |
P698 | PubMed publication ID | 21943112 |
P5875 | ResearchGate publication ID | 51670242 |
P50 | author | Matti Uusitupa | Q16991089 |
Jaakko Tuomilehto | Q28050079 | ||
Jaana Lindström | Q56947407 | ||
Pirjo Ilanne-Parikka | Q86871378 | ||
Leena Pulkkinen | Q117253180 | ||
Niina Siitonen | Q117253193 | ||
Johan G. Eriksson | Q37632234 | ||
Sirkka Keinänen-Kiukaanniemi | Q39201566 | ||
Marjukka Kolehmainen | Q42170406 | ||
P2093 | author name string | Ursula Schwab | |
P2860 | cites work | Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin | Q22010955 |
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages | Q24290861 | ||
Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell | Q24299893 | ||
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q24304889 | ||
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 | ||
Statistical significance for genomewide studies | Q24681264 | ||
The International HapMap Project | Q27860695 | ||
Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
Efficiency and power in genetic association studies | Q28278645 | ||
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
Adipokines in inflammation and metabolic disease | Q29620456 | ||
Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial | Q33455816 | ||
Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes | Q33758866 | ||
Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. | Q53631333 | ||
Hepatic adiponectin receptors (ADIPOR) 1 and 2 mRNA and their relation to insulin resistance in obese humans. | Q53775867 | ||
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions | Q57249776 | ||
Adiponectin and Coronary Heart Disease | Q57416324 | ||
Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1interact with plasma saturated fatty acids to modulate insulin resistance | Q59607705 | ||
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice | Q64378290 | ||
Association of hypoadiponectinemia with coronary artery disease in men | Q78780687 | ||
Common haplotypes at the adiponectin receptor 1 (ADIPOR1) locus are associated with increased risk of coronary artery disease in type 2 diabetes | Q79143549 | ||
Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: a tagging-single nucleotide polymorphism haplotype analysis | Q80117562 | ||
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state | Q80558968 | ||
Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population | Q82676205 | ||
Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes | Q83935963 | ||
The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents | Q33896882 | ||
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia | Q33946056 | ||
The International HapMap Project Web site | Q34206586 | ||
Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes | Q34315956 | ||
Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance | Q34336221 | ||
Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism | Q34343566 | ||
Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish | Q34429449 | ||
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study | Q34580894 | ||
Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease | Q34592893 | ||
Genomewide association studies and human disease | Q34606556 | ||
Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome | Q34695582 | ||
Adiponectin and its receptors in non-alcoholic steatohepatitis. | Q35597147 | ||
Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations | Q35629049 | ||
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement | Q36342283 | ||
Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes | Q36839329 | ||
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis | Q38361016 | ||
Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. | Q39984242 | ||
Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. | Q42484914 | ||
Decreased plasma adiponectin concentrations in women with dyslipidemia | Q44018162 | ||
Adiponectin stimulates production of nitric oxide in vascular endothelial cells. | Q44565932 | ||
The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity | Q44666271 | ||
Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis. | Q46314424 | ||
Association of ADIPOR2 with liver function tests in type 2 diabetic subjects | Q46417040 | ||
Expression of ghrelin gene in peripheral blood mononuclear cells and plasma ghrelin concentrations in patients with metabolic syndrome | Q46685986 | ||
Opposing effects of adiponectin receptors 1 and 2 on energy metabolism | Q48259094 | ||
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. | Q50650486 | ||
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. | Q51431569 | ||
Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. | Q51490522 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Finland | Q33 |
glucose | Q37525 | ||
cardiovascular disease | Q389735 | ||
glycobiology | Q899224 | ||
type 2 diabetes | Q3025883 | ||
P304 | page(s) | 83 | |
P577 | publication date | 2011-09-24 | |
P1433 | published in | Cardiovascular Diabetology | Q2468083 |
P1476 | title | Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study | |
P478 | volume | 10 |
Q64094055 | Adiponectin Receptor gene Polymorphisms are Associated with Kidney Function in Elderly Japanese Populations |
Q36288862 | Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes |
Q35963270 | Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients |
Q36392003 | Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. |
Q27027840 | Cardiometabolic effects of adiponectin |
Q38176765 | Cardiovascular risk in children and adolescents with type 2 diabetes mellitus |
Q36828075 | Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes |
Q36521802 | Gly1057Asp polymorphism of insulin receptor substrate-2 is associated with coronary artery disease in the Taiwanese population |
Q35451840 | Single nucleotide polymorphism-single nucleotide polymorphism interactions among inflammation genes in the genetic architecture of blood pressure in the Framingham Heart Study |
Q34479338 | Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study |
Q37363488 | Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. |
Q49960522 | Variations in ADIPOR1 But Not ADIPOR2 are Associated With Hypertriglyceridemia and Diabetes in an Admixed Latin American Population. |
Search more.